Stamford, CT -- (SBWIRE) -- 01/28/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Frontline Ltd. (NYSE:FRO), Endeavour Silver Corp (NYSE:EXK), Exelixis, Inc. (NASDAQ:EXEL), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
Frontline Ltd. (NYSE:FRO) opened the session at $4.62, trading in a range of $1.71- $4.62. The stock showed a negative performance of -7.49% in the last trading session from its previous close of $4.67 and closed at $4.32. The stock traded on a volume of 2.50 million shares and the average volume of the stock remained 2.44 million shares. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt. The Company operates through subsidiaries and partnerships located in the Bahamas, Bermuda, the Cayman Islands, India, the Isle of Man, Liberia, Norway, the United Kingdom and Singapore.
Has FRO Found The Bottom and Ready To Move Up? Find Out Here
Endeavour Silver Corp (NYSE:EXK) traded 2.38 million shares in the last business day while the average volume of the stock remained 1.37 million shares. The stock showed a negative movement of -7.21% to end at $4.12. The 52 week range of the stock remained $2.88 - $7.51. Endeavour Silver Corp. (Endeavour) is engaged in the evaluation, acquisition, exploration, development and exploitation of silver mining properties in Mexico and in exploration in Chile. The Company’s producing mines include Guanacevi mine, Bolanitos Mine and El Cubo. The Guanacevi Mines Project and the Bolanitos Mines Project have been the primary focus of business activity.
Has EXK Found The Bottom And Ready To Gain Momentum? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) reported 6.00 million shares were exchanged during the last trade, while the average volume is about 3.17 million shares. The stock dropped -7.07% and finished the day at $7.10.The beta of the stock is recorded at 1.99. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is being evaluated in a development program encompassing multiple cancer indications.
Why Should Investors Buy EXEL After the Recent Fall? Just Go Here and Find Out
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares dropped -6.42 percent from its previous close of 1.87to close at $1.75. Traded with volume of 1.49 million shares in the prior session and the average volume of the stock remained 1.41 million shares. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets.
Will LXRX Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)